R
ecently, a general method was developed that makes possible the addition of new amino acid building blocks to the genetic codes of Escherichia coli (1) and Saccharomyces cerevisiae (2) . In this approach, an orthogonal transfer RNA (tRNA)-aminoacyl tRNA synthetase pair is evolved that uniquely recognizes the amino acid of interest and selectively incorporates it into proteins in response to the amber nonsense codon, TAG. This methodology has been used to site-specifically incorporate a variety of unnatural amino acids into proteins with high fidelity and good efficiency, including amino acids with novel functional groups (3) (4) (5) (6) , photocrosslinkers (7, 8) , heavy atoms, sugars (9) , and redox active moieties. In addition, new orthogonal tRNA-synthetase pairs have been evolved from leucyl (10) , lysyl, glutaminyl (11) , aspartyl (12) , and tyrosyl (13) tRNA-synthetase pairs to expand the number and structural diversity of amino acids that can be genetically encoded in bacteria and yeast.
In an effort to extend this methodology to mammalian cells, two general approaches are being developed. The first involves the directed evolution of an orthogonal tRNA-synthetase pair with a desired specificity in yeast and the subsequent adaptation of this pair for expression in mammalian cells (2) . This approach has the advantage that large libraries of tRNA synthetases can be generated in yeast, and a mutant with the desired specificity can be efficiently isolated using an appropriate genetic selection or screen. Alternatively, one can use structure-based design to generate a mutant orthogonal tRNA-synthetase pair with altered specificity directly in mammalian cells. Recently, Yokoyama and coworkers (14, 15) used a variant of the former approach to generate a heterologous orthogonal pair consisting of a Bacillus stearothermophilus amber suppressor tRNA Tyr and mutant E. coli tyrosyl-tRNA synthetase that was able to incorporate 3-iodo-L-tyrosine into proteins in mammalian cells with 95% fidelity. To further expand the number of unnatural amino acids that can be genetically encoded in mammalian systems, we now report the generation of an orthogonal mammalian tRNA-synthetase pair from a Bacillus subtilis tryptophanyl tRNA and cognate synthetase. Moreover, we show that directed mutagenesis of this pair can be used to generate a mutant synthetase that efficiently inserts 5-hydroxytryptophan (5-HTPP) into proteins in response to the opal codon TGA with excellent fidelity. This amino acid has novel spectroscopic and electrochemical properties that can be used to probe protein structure and function both in vitro and in vivo.
Materials and Methods
General. Mammalian cells were transfected with FuGENE 6 reagent (Roche Applied Science, Indianapolis). Radio-labeled amino acids were obtained from Perkin-Elmer, and oligonucleotides were from Proligo (La Jolla, CA). Genomic DNAs were obtained from American Type Culture Collection (Manassas, VA). Antibodies, antibiotics, and TRIzol solution were purchased from Invitrogen. V5-antibody-immobilized agarose was purchased from Bethyl Laboratories (Montgomery, TX); and anti-His6 (C-terminal) antibody was purchased from Qiagen (Valencia, CA). 5-HTPP was from Sigma and was used without further purification. Nucleobond columns were purchased from Clontech.
Strains. E. coli strains DH10B and TOP10 were used for plasmid propagation and isolation. Human kidney 293T cells were used for unnatural amino acid incorporation into proteins.
Plasmids. The DNA fragment encoding B. subtilis tryptopanyltRNA synthetase (BsTrpRS) was amplified from genomic DNA by PCR and cloned into the XhoI-PacI sites of the pMH4 vector (Genomics Institute of the Novartis Research Foundation, La Jolla, CA). The resulting plasmid pMHTrpRS encodes BsTrpRS with a His6 tag at the N terminus in E. coli. To express BsTrpRS in mammalian cells, the PCR fragment encoding the synthetase was ligated into a pEF6-V5-His6-TOPO vector (Invitrogen). The resulting plasmid pEF6-TrpRS encodes WT B. subtilis TrpRS with C-terminal V5 and His6 epitope tags. A series of mutant synthetases was generated in this vector by site-directed mutagenesis by using QuikChangeXL (Stratagene) and mutagenic primers.
The mutant opal suppressor tRNA Trp (mutRNA UCA Trp ) gene was constructed by annealing two oligodeoxynucleotides. The first encodes the corresponding mutRNA UCA Trp sequence fused to the 5Ј-f lanking sequence (TAAAATTAATTAAACGTTTA-GAAATATATAGATGAACTTTATAGTACAA) of the tRNA gene (16) . The second oligonucleotide consists of the corresponding mutRNA UCA Trp fused to the 3Ј-flanking sequence GTCCTTTTTTTG (16) . Klenow was used to generate a duplex DNA, which was inserted into the PstI and XhoI sites of pZeoSV2(ϩ) (Invitrogen). The resulting plasmid pTrptRNA can be used to transcribe mutRNA UCA Trp in mammalian cells. The plasmid pFoldon, which was used to express the bacteriophage T4 fibritin (foldon) domain (17) in 293T cells, was con-structed by inserting the PCR-amplified gene fragment into the pCDA3.1-V5-His-TOPO vector (Invitrogen). pFoldonTGA, which encodes the Trp68TGA foldon mutant, was constructed by sitedirected mutagenesis by using the QuikChangeXL method and the corresponding HPLC-purified primers.
Expression and Detection of mutRNA UCA Trp in Mammalian Cells. Mammalian 293T cells were transfected with plasmid pTrptRNA by using FuGENE 6 and incubated at 37°C under 5% CO 2 for 60 h. Cellular RNA was extracted with TRIzol solution according to manufacturer's instructions (Invitrogen), and the total tRNA was then isolated by using a NucleoBond column according to the manufacturer's protocol (Clontech). The yield and purity of the purified tRNA were analyzed by a 3% agarose gel. To detect the mutRNA UCA Trp , the purified tRNAs were first blotted and then crosslinked onto nylon transfer membranes (Osmonics, Westborough, MA) by UV irradiation by using Stratalinker 2400 (Stratagene) for 1 min. After irradiation, the membrane was incubated in 100 ml of hybridization buffer (0.9 M NaCl͞0.09 M sodium citrate, pH 7.0͞1% SDS͞5ϫ Denhardt's reagent with 25 g/ml sperm whale DNA) and gently shaken at 68°C for 1 h. The oligonucleotide, CGGAGGTTTTGAAGACCT, which is complementary to nucleotides 27-44 of the suppressor tRNA, was 5Ј-labeled with [␥-32 P]ATP and used to probe the membrane at 50°C for 6 h. The membrane was then washed three times with wash buffer (15 mM NaCl͞1.5 mM sodium, pH 7.0͞0.1% SDS). The intensity of each dot was quantified by using a PhosphorImager (Molecular Dynamics).
Expression of B. subtilis TrpRS in Mammalian 293T
Cells. Cells were transfected with the plasmid pEF6-TrpRS by using FuGENE 6 and incubated at 37°C under 5% CO 2 for 60 h. Cells were harvested and lysed with 1ϫ passive lysis buffer (Promega), and the cell lysate was centrifuged at 20,000 ϫ g. Proteins were separated by denaturing SDS͞PAGE and then transferred to a nitrocellulose membrane. Proteins were probed with anti-V5 antibody (Invitrogen). Substrate (SuperSignal West Dura, Pierce) was applied to visualize the signals.
In Vitro Aminoacylation Assay. Aminoacylation assays were performed by methods described previously (18) Opal Suppression in Mammalian Cells. Transfections were carried out with FuGENE 6 by using a total of 9 g of DNA per 9.5-cm 2 plate according to the manufacturer's protocol (Roche Applied Sciences). Minimum essential ␣ medium (GIBCO͞BRL) was used as the growth medium. Cell extracts were prepared 48 h after transfection and subjected to SDS͞PAGE, followed by Western blot using anti-V5 antibody (Invitrogen) and the SuperSignal West Dura immunodetection system (Pierce). Signals were detected by exposing the membrane to Hyperfilm MP (Amersham Pharmacia) and quantified by using Eagle Eye Imaging System (Stratagene).
Unnatural Amino Acid Incorporation in Mammalian Cells. Mammalian 293T cells were cotransfected with plasmids pTrptRNA, pFoldonTGA, and individual mutant pEF6-TrpRS by using Fu-GENE 6 as previously described. After 24 h, the culture medium was changed to minimum essential ␣ medium containing 1 mM 5-HTPP and appropriate antibiotics. After an additional 48 h at 37°C under 5% CO 2 , cells were harvested, lysed with 1ϫ passive lysis buffer (Promega), and the cell lysate collected by centrifugation at 20,000 ϫ g. The foldon protein containing 5-HTPP was purified from the cell lysate (20, 50-ml culture plates) with Ni-NTA beads followed by anti-V5-immobilized agarose beads according to manufacturer's protocol (Bethyl Laboratories). An aliquot of the purified protein was subjected to high-resolution electrospray ionization mass spectrometry.
Fluorescence Spectroscopy. Proteins were diluted to a final concentration of 50 nM in 10 mM K 2 PO 4 ͞100 mM KCl buffer at pH 7.5. Fluorescence spectra were measured on a Fluromax-2 spectrofluorimeter and corrected. Emission spectra were recorded with excitation and emission bandpass of 3 nm.
Electrochemical Characterization of Proteins Containing 5-HTPP.
A conventional three-electrode cell, consisting of a gold electrode, a glassy carbon auxiliary electrode isolated by a glass frit, and a saturated calomel electrode (SCE) connected to the working volume with a Luggin capillary, was used for electrochemical measurements. The cell was placed in a grounded Faraday cage. Cyclic voltammetry measurements were performed by using a potentiostat (Princeton Applied Research, Oak Ridge, TN, model VMP2) connected to network-operated software EC-LAB Version 6.61. All electrochemical measurements were performed in 0.1 M phosphate buffer, pH 7.4, under argon atmosphere. Substrate 5-HTPP was dissolved in 100 mM phosphate buffer to a final concentration of 10 g͞ml. Potentials were measured in the range of 0-800 mV at a scan rate of 1 V⅐sec Ϫ1 . For crosslinking experiments, the electrode potential was set to 800 mV for 30 min in the presence of 10 g͞ml WT foldon or 5-HTPP-foldon protein͞0.1 M phosphate buffer, pH 7.4, under argon atmosphere. After that, the solutions were collected, and proteins were desalted by dialysis, concentrated, and loaded on a gel for further analysis.
Results and Discussion
An Orthogonal Opal Suppressor tRNA for Use in Mammalian Cells. To genetically encode an unnatural amino acid in mammalian cells, one must generate an orthogonal tRNA that is not recognized by any of the endogenous aminoacyl tRNA synthetases and that, at the same time, efficiently incorporates its cognate amino acid in response to a unique codon (in this case, the opal nonsense codon TGA). A corresponding aminoacyl-tRNA synthetase is also required that uniquely recognizes this tRNA and selectively charges it with the unnatural amino acid and no endogenous amino acids. One approach to the generation of orthogonal tRNA-synthetase pairs takes advantage of interspecies differences in tRNA recognition elements (19) . For example, Xue and coworkers (20) have shown that B. subtilis tRNA Trp is not a substrate for the tryptophantRNA synthetases from yeast and mammalian cells (21) . Thus B. subtilis tRNA Trp is a likely candidate for an orthogonal suppressor tRNA in mammalian cells.
Unfortunately, when we attempted to express B. subtilis tRNA Trp in 293T cells, no transcribed RNA was observed based on Northern blot analysis of isolated total tRNA (see below) (22) . Therefore, a series of modifications were made to the B. subtilis suppressor tRNA Trp (Fig. 1) . tRNAs in eukaryotes are transcribed by RNA polymerase III, which recognizes two conserved intragenic transcriptional control elements, the A and B boxes (23) . Because the B. subtilis tRNA Trp sequence contains only the B box, nucleotides A7, A9, and U11 were changed to G7, G9, and C11 to generate a pseudo-A box, and the resulting mismatched base pairs G7-U64 and C11-A23 were replaced with G7-C64 and C11-G23, respectively. In vitro kinetic data showed that the A9G and U11C mutations have minor effect on B. subtilis TrpRS recognition (21) . Expression of the tRNA Trp gene in eukaryotes also depends on 5Ј flanking sequences, which are distinctly AT rich and contain several possible TATA elements (16) . Therefore, we added the 5Ј flanking sequence of the tRNA Trp-1 gene from Arabidopsis (Trp-1), which was previously shown to enhance the transcription of the plant tRNATrp gene in human 293T cells (16) . Because a properly positioned terminator element is the only 3Ј flanking sequence required for efficient expression of the plant tRNA Trp gene, the natural 3Ј flanking sequence of the same tRNA gene was used. Finally, the trinucleotide anticodon sequence CCA was changed to the opal suppressor UCA.
Expression of the modified opal suppressor tRNA Trp (mutRNA UCA Trp ) was verified by Northern blot assay. The mutRNA UCA Trp gene, together with its 5Ј and 3Ј flanking sequences, was cloned into the mammalian vector pZeoSV2(ϩ), and the resulting plasmid was transfected into human 293T cells with FuGENE 6. Total tRNA was then isolated and blotted onto a membrane. As a control, the same amount of total tRNA from human 293T cells, beef liver, and E. coli was also transferred onto the same membrane ( Fig. 2A) . A synthetic oligonucleotide complementary to nucleotides 27-44 of the mutRNA UCA Trp and labeled with [␥-32 P]ATP was used as a probe for the mutRNA UCA Trp . Only the total tRNA isolated from transfected 293T cells produced a signal (Fig. 2B, lane 4) ; the control tRNAs gave no signal when incubated with the radioactive probe (Fig. 2B, lanes 1-3) Protein from cell lysate was separated by SDS͞PAGE and analyzed by Western blot (with an anti-C-terminal V5 antibody). A band corresponding to the full-length prokaryotic BsTrpRS protein (Ϸ36 kDa) was observed, demonstrating that the synthetase can be expressed in mammalian cells at reasonable levels (Fig. 4A, lane 1) . No significant effect on growth rates was observed on expression of the B. subtilis TrpRS.
To analyze the suppression of the BsTrpRS-mutRNA UCA Trp pair, the codon for Trp-68 in a modified bacteriophage T4 fibritin foldon gene under the control of a cytomegalovirus promoter (17) was mutated to the opal codon, TGA. To detect the expression of the full-length foldon protein, both a V5 epitope tag and a His6 tag were fused to the C termini of the WT (pFoldonWT) and mutant proteins (pFoldonTGA). The corresponding foldon genes were transfected into human 293T cells along with either one or both of the BsTrpRS and mutRNA UCA Trp genes using FuGENE 6. Full length protein was detected by a Western blot of the cell extracts with anti-V5 antibody (Invitrogen).
No full-length protein was expressed when 293T cells were transfected only with the mutant foldon gene (pFoldonTGA) (lane 1, Fig. 3 ) or the mutant foldon gene and WT BsTrpRS (lane 2, Fig.  3 ). These results show that human 293T cells do not contain intrinsic opal suppressors of the TGA68 mutation. Suppression of the opal mutation was also not observed in the absence of WT BsTrpRS and in the presence of mutRNA UCA Trp (Fig. 3, lane 3) , confirming that the mutRNA UCA Trp is not charged by endogenous synthetases in human 293T cells. In contrast, in the presence of mutRNA UCA Trp , WT BsTrpRS and the TGA68 mutant foldon gene, expression of full-length protein was detected (Fig. 3, lane 4 Site-Specific Incorporation of 5-HTPP into Mammalian Cells. We next determined whether the orthogonal mutRNA UCA Trp -BsTrpRS pair could be used to selectively incorporate 5-HTPP into proteins in mammalian cells in response to the opal nonsense codon. This amino acid has unique spectroscopic and redox properties that can serve as useful probes of protein structure and function both in vitro and in vivo and has minimal toxicity up to 1 mM in growth media. Initially, we attempted to subsitute 5-HTPP for Trp-68 in foldon. Previously, experiments have shown that mutation of Trp-68 to either tyrosine or phenyalanine does not significantly disrupt protein folding (27) . Moreover, modeling studies (using INSIGHT II), together with the available x-ray crystal structure of foldon, suggest that the 5-position of Trp in foldon is solvent exposed (27) . Therefore, substitution of Trp with Trp analogues containing substituents at the 5-position is unlikely to disrupt the structure of this protein.
It is known that WT B. subtilis TrpRS does not use 5-HTPP as a substrate (28) . Therefore, to use BsTrpRS to selectively incorporate 5-HTPP into proteins, the active site of the synthetase must be mutated to charge 5-HTPP and not tryptophan. Although the structure of BsTrpRS has not yet been solved, the structure of a highly homologous tryptophanyl-tRNA synthetase (from Bacillus stearothermophilus) has been solved to 1.9-Å resolution (29) (30) (31) . In this enzyme, the active site has a figure eight-like shape with two adjacent binding pockets separated by an ␣-helix peptide consisting of residues Asp-140, Ile-141, Val-142, Pro-143, Val-144, and Gly-145. Val-144 points directly toward C5 of tryptophan, providing unfavorable steric interactions with any tryptophan analogue con-
To test this notion, Val-144 of WT BsTrpRS was mutated to each of the other 19 amino acids by site-directed mutagenesis, and each mutant was assayed for its ability to aminoacylate mutRNA UCA Trp with 5-HTPP by suppressing the TGA68 in the mutant foldon gene. The transfected cells were then grown in the presence or absence of 1 mM 5-HTPP, and full-length protein was detected by Western blot of the cell extracts with an anti-V5 antibody (Fig. 4A) . Expression of a full-length foldon protein in the presence of 5-HTPP would indicate that either 5-HTPP or a natural amino acid (likely tryptophan) is incorporated at position 68 of the foldon protein. One can exclude the incorporation of a natural amino acid by showing that no full-length protein is expressed in the absence of 5-HTPP under otherwise equal conditions. Among the 19 TrpRS mutants, the Val-1443Gly mutant was able to suppress the TGA68 codon in the presence of 1 mM 5-HTPP and mutRNA UCA Trp . However, in the absence of 5-HTPP, the mutant BsTrpRS and mutRNA UCA Trp were still able to suppress the opal mutation, indicating the Val-1443GlyBsTrpRS mutant also charges a natural amino acid. Only one other TrpRS mutant, Val-1443 ProBsTrpRS, was able to suppress the TGA68 mutation in the presence of 1 mM 5-HTPP and mutRNA UCA Trp (Fig. 4A, lane 5) . Moreover, human 293T cells containing the Val-1443ProB-STrpRS and the TGA68 foldon gene were unable to produce full-length protein in the absence of either 5-HTPP or mutRNA UCA Trp (Fig. 4A, lanes 2-4) . These results show that the Val-1443ProB- sTrpRS mutant selectively aminoacylates the mutRNA UCA Trp with 5-HTPP and not with any endogenous amino acids. Protein was found only in the soluble fraction of the cell lysate.
To confirm that the expressed mutant protein contains 5-HTPP, the protein was purified first by Ni-NTA affinity chromatography and, subsequently, by immunoprecipitation using anti-V5-immobilized agarose beads. An aliquot of the purified protein was subjected to high-resolution electrospray ionization mass spectrometry. The calculated molecular mass of the HTPP68 mutant protein is 14,323.6 Da; the observed molecular mass is 14,323.69 Da (Fig.  4B) . No peak corresponding to WT foldon protein was observed. This result clearly demonstrates that 5-HTPP is incorporated with high fidelity (Ͼ97%) into protein in response to the opal codon in mammalian cells.
It is somewhat surprising that a single mutation at the active site of BsTrpRS completely alters its specificity from L-tryptophan to 5-HTPP. Although the x-ray crystal structure is not yet available, molecular modeling with INSIGHT II suggests that the Val-1443Pro mutation generates space for the indole ring to rotate and abolishes an indole NHOAsp hydrogen bond. This may explain why the Val-1443ProBsTrpRS does not charge L-tryptophan. However, new hydrogen bonds are formed in the case of 5-HTPP with the 5-OH group hydrogen bonding with the imidazole side chain of His-44 and the carboxylate group of Asp-133, and the indole NH hydrogen bonding with the hydroxyl group of Ser-7 (Fig. 5) . (35) . WT foldon protein has only one tryptophan residue, which is substituted in the mutant foldon protein with 5-HTPP. To compare the fluorescence properties of these two proteins, they were purified and then excited at 310 nm at pH 7.4, and their emission spectra were recorded (Fig. 6) . The HTPP68 foldon protein has an emission maximum, max at 334 nm, whereas the WT foldon protein has a fluorescence max at 367 nm. When both proteins are excited at 310 nm, the magnitude of fluorescence emission at 334 nm from HTPP68foldon protein is 11 times than that from WT foldon protein. Such spectral changes may make 5-HTPP a useful optical probe for some applications (29).
5-HTPP as a Probe for
5-HTPP can also undergo redox chemistry to afford tryptophan-4,5-dione (32) . Cyclic voltammetry was used to determine whether the redox wave of 5-HTPP could be observed in the HTPP68foldon mutant. The voltammetric responses were measured for solutions containing 10 M of HTPP, WT foldon, or the foldon mutant. An anodic current originating from HTPP oxidation appears only in the presence of the mutant foldon or in a solution of free 5-HTPP with E Pa ϭ 400 mV and E Pa ϭ 450 mV [vs. saturated calomel electrode (SCE)], respectively, indicating the presence of 5-HTPP in the mutant foldon. The slight decrease in the oxidation potential for the mutant protein probably results from differential stabilization of the oxidized and reduced forms of 5-HTPP in aqueous solution vs. the hydrophobic protein core (33, 34) . No current was observed on attempts to oxidize the WT foldon (data not shown).
On electrochemical oxidation of 5-HTPP at a potential 800 mV in 7.4 phosphate buffer, the dimer (Fig. 7A1) is formed (32) . Similarly, 5-HTPP can be oxidatively crosslinked to glutathione via its cysteine residue (Fig. 7A2) . Therefore a 5-HTPP residue incorporated selectively into a protein might be useful as a redox There is no crosslinked product for WT foldon, which has a monomeric molecular mass of 14.5 kDa. HTPP68foldon is crosslinked to afford a dimeric 29-kDa protein.
